Mark R Dowling

11PUBLICATIONS
56CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 07, 2026
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

|Aug 20, 2026
Richter transformation: emerging immunologic strategies beyond chemoimmunotherapy.

|Feb 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey

|Jul 11, 2025
Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomics.

Raymond K H Yip, Jeremy Er, Lei Qin

|Sep 19, 2024
Neuropsychological outcomes of patients with haematological malignancies undergoing chimeric antigen receptor T-cell therapy: protocol for a prospective study.

Valeriya Kuznetsova, Harsh Oza, Hannah Rosenfeld

|Oct 28, 2022
Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune response.

Marcus James Robinson, Mark R Dowling, Catherine Pitt

Pageof 2

Frequent Collaborators

7 joint publications

Simon J Harrison

4 joint publications

Michael J Dickinson

4 joint publications

Mary Ann Anderson

3 joint publications

Constantine S Tam